Martin van den Bent

Martin van den Bent has led European clinical trials evaluating TTFields and has contributed to understanding how molecular subtypes of glioblastoma may differentially respond to electric field therapy. His work on brain tumor classification and treatment stratification informs precision approaches to TTFields application. He has advanced the integration of TTFields into European treatment guidelines and clinical trial networks.